1 / 24

Corticosteroid Therapy in Asthma

Corticosteroid Therapy in Asthma. Attaran D, MD,Pulmonologist , Associate professor , Mashhad University of Medical Sciences. Definition of Asthma. A chronic inflammatory disorder of the airways Many cells and cellular elements play a role

jela
Download Presentation

Corticosteroid Therapy in Asthma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Corticosteroid Therapy in Asthma Attaran D, MD,Pulmonologist , Associate professor , Mashhad University of Medical Sciences

  2. Definition of Asthma • A chronic inflammatory disorder of the airways • Many cells and cellular elements play a role • Chronic inflammation is associated with airway hyperresponsiveness that leads to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing • Widespread, variable, and often reversible airflow limitation

  3. Introduction Steroids are the most effective therapy for asthma  Steroids are recommended as the first line therapy for all patients  Inhaled steroids have been a great advance in the management of asthma  Inhaled steroids control inflammation & symptoms without significant side effects

  4. Molecular effects of corticosteroids  Anti inflammatory gene activation  Switching off inflammatory genes  Inflammatory cell inhibition ( lymph , Mast cell, Eos , Mac )  Increased B2 receptor effects  Steroids have no distinct effects on airway muscle

  5. Asthma Inflammation: Cells and Mediators Source: Peter J. Barnes, MD

  6. AsthmaInflammation: Cells and Mediators Source: Peter J. Barnes, MD

  7. Clinlcal use  A single dose of steroids has no effect on the early response to allergen But does inhibit the late response  The fraction of steroid that is inhaled acts locally on the airway mucosa  Systemic absorption from airway, alveolar surface & oropharyngeal swallowing  Absorbed fraction metabolized in the liver ( first pass metabolism )  Budesonide & Fluticasone have a greater first pass metabolism

  8. Estimate Comparative Daily Dosages for Inhaled Glucocorticosteroids by Age Drug Low Daily Dose (g) Medium Daily Dose (g) High Daily Dose (g) > 5 y Age < 5 y > 5 y Age < 5 y > 5 y Age < 5 y

  9.  Use of spacer reduce oropharyngeal deposition and complications  Low dose inhaled steroid up to 400mcg BDP ( 250mcg Fluticasone )  Medium dose inhaled steroid up to 1000mcg BDP ( 500mcg F )  High dose inhaled steroid up to 2000mcg BDP (1000mcg F)

  10. In acute severe asthma maximal beneficial effectis usually achieved with 30-40 mg Prednisolone daily •  Usual maintenance dose is 10-15 mg •  Oral steroids are usually given as a single dose in the morning

  11. Steroid Complications  Suppression of HPA axis (dose dependent & duration)  Systemic effects  Localized effects

  12. Steroid Resistant (SR) Asthma Failure to improve FEV1 > 15 % following 7-14days of 20 mg prednisolone Type1 :Acquired or cytokine induced ,GR normal, GR binding affinity low Steroid side effects yes, reversible and > 95 %SR patients Type 2 :Genetic ,GR low ,GR binding affinity normal ,Steroid side effects no, irreversible and< 5%

  13. Steroid Insensitive Asthma  Relative insensitivity to steroids  Response to higher dose and prolonged periods  More common than SR asthma ( 10-30 % patients )

  14. Diagnosis  Severe asthma  Persistent respiratory symptoms  Frequent nocturnal symptoms FEV1< 60-70%  Systemic steroid therapy at young age  Higher maintenance dose of oral steroid

  15. Management of SR or SI Asthma  Evaluation for comorbid or masquerading conditions  VCD,GERD, ABPA,HP,Upper airway dis  Assessing of persistent tissue inflammation ( e NO , ECP )  Ensure adequate treatment adherence

  16.  Possible microbial infection ( MP , CP )  Combination therapy with LABA  Final step is use of alternative anti inflammatory & immunomedulatory ( Omalizomab ,Cyclospurine ,IV Ig )

  17. خدايا به من آرامشي عطا فرما • تا بپذيرم آنچه را نمي توانم تغيير دهم • و شهامتي تا تغيير دهم آنچه را مي توانم • و دركي تا بفهم تفاوت اين دو را • خدايا به من آرامشي عطا فرما • تا بپذيرم آنچه را نمي توانم تغيير دهم • و شهامتي تا تغيير دهم آنچه را مي توانم • و دركي تا بفهم تفاوت اين دو را

More Related